Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2000British Journal of CancerOpen Access

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

View Full Paper
Ask AI
Bookmark
Share

Authors

WYW.K. Alfred YungThe University of Texas MD Anderson Cancer CenterRARobert E. AlbrightUniversity of IowaJOJeffrey J. OlsonEmory University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yung et al. (2000) studied this question.

synapsesocial.com/papers/6a085a3dab15ea61dee8ca2fhttps://doi.org/10.1054/bjoc.2000.1316
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors1989 · 82 citations
  2. 2Procarbazine hydrochloride in the treatment of brain tumors1974 · 97 citations